Drugs / natural killer and natural killer T cell
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03198923 | Sep 2017 → Dec 2018 | non-small cell lung carcinoma | Wenxiang Wang | Unknown | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | natural killer and natural killer T cell | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03198923 ↗ |